Sheldon Greenfield
Papers
3
Total Citations
84
H-Index
3
About
Sheldon Greenfield is a leading health services researcher whose work has fundamentally shaped how we measure and improve the quality of care for men with prostate cancer. His research centers on comparative effectiveness, patient-reported outcomes, and the rigorous assessment of surgical quality in real-world settings. A landmark contribution, his 2015 study on "The Comparative Harms of Open and Robotic Prostatectomy" (64 citations) used population-based cohorts to challenge assumptions about the superiority of robotic surgery, revealing nuanced differences in functional outcomes. Greenfield also advanced the interpretation of the widely-used EPIC-26 questionnaire (13 citations), translating domain scores into clinically meaningful functional outcomes to help patients set realistic expectations. His leadership in the CEASAR study (7 citations) demonstrated that nationally endorsed quality measures often fail to correlate with actual patient outcomes, advocating for more outcome-linked metrics. By bridging the gap between clinical trials and everyday practice, Greenfield has provided surgeons and patients with the evidence needed to make informed treatment decisions, cementing his role as a pivotal figure in urologic oncology and outcomes research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3